Stay updated with breaking news from Sun Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sharekhan had the most bullish earnings target for Sun Pharma, while Kotak Institutional Equities pegged the least growth.
Senator Thom Tillis (R-NC) has been unsuccessfully trying to obtain information from the Food and Drug Administration (FDA) and the United States Patent and Trademark Office (USPTO) on data being used to support drug pricing proposals for nearly two and a half years.
Q4 Results today: ONGC, IRFC, Bharat Electronics, Whirlpool India, are among the top companies to declare their Q4 scorecard today
Solara Active Pharma Sciences Ltd's Visakhapatnam facility receives positive USFDA inspection with zero observations, ensuring compliance and quality.
Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The